跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NICOTINAMIDE RIBOSIDE LIPOSOMAL - TGA Drug Approval Details
Approvals
/
TGA
/
NICOTINAMIDE RIBOSIDE LIPOSOMAL
Approved
STANDARD
NICOTINAMIDE RIBOSIDE LIPOSOMAL
Melrose Laboratories Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
e4fb5e1d59434ca4
Company
Melrose Laboratories Pty Ltd
Type
Standard
Approval Details
Approval Id
e4fb5e1d59434ca4
Product Name
NICOTINAMIDE RIBOSIDE LIPOSOMAL
Artg Id
400325
Artg Name
NICOTINAMIDE RIBOSIDE LIPOSOMAL
Sponsor
Melrose Laboratories Pty Ltd
Company Detail Path
/organization/melrose-laboratories-pty-ltd
Artg Date
2022-11-29
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
LI
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
e4fb5e1d59434ca4
Type
Standard
Back to TGA Approvals